Modulatory effects of inflammation and therapy on GDF‐5 expression in rheumatoid arthritis synovium
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 37 (6) , 401-409
- https://doi.org/10.1080/03009740802120010
Abstract
Objective: Growth differentiation factor‐5 (GDF‐5), a member of the transforming growth factor (TGF)‐β family, is involved in joint development during embryogenesis and has the potential to regenerate cartilage in adult animals. As progression of chronic joint diseases is influenced by cytokines of the synovial tissue, we examined the expression and effects of GDF‐5 in this tissue. Methods: Microarray experiments were investigated for differential expression of GDF‐5 in synovial tissues, synovial fibroblasts, and peripheral blood cells. GDF‐5 expression was validated by semiquantitative reverse transcriptase polymerase chain reaction (RT‐PCR), immunohistochemistry, double immunofluorescence, and in situ hybridization in synovial tissue of normal donors (ND) and patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Effects of inflammation and therapy were investigated in RA and OA fibroblasts after stimulation with interleukin (IL)‐1β, tumour necrosis factor (TNF)‐α, methotrexate (MTX), and prednisolone. The influence of GDF‐5 on macrophages was studied by chemotaxis assay. Results: Microarray analysis and immunostaining revealed expression predominantly in synovial fibroblasts. Compared to patients without immunomodulating drugs, expression of GDF‐5 was decreased significantly in patients receiving glucocorticoids and/or disease‐modifying antirheumatic drugs (DMARDs) (p = 0.007), but did not differ between the total group of ND, OA, and RA. Stimulation with prednisolone and TNFα reduced GDF‐5 expression in OA and RA fibroblasts, whereas MTX and IL‐1β revealed minor or no relevant change. GDF‐5 also reduced cell migration of macrophages (p<0.001). Conclusion: GDF‐5 is expressed in synovial fibroblasts and may counteract macrophage infiltration. Its modulation by inflammation and therapy suggests that glucocorticoids play a conflicting role by suppressing not only inflammation but also putative mechanisms of repair.Keywords
This publication has 30 references indexed in Scilit:
- Isolation and characterization of synovial cells from the human temporomandibular jointJournal of Oral Pathology & Medicine, 2006
- Tumour necrosis factor (TNF)α −308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritisScandinavian Journal of Rheumatology, 2006
- Piascledine modulates the production of VEGF and TIMP‐1 and reduces the invasiveness of rheumatoid arthritis synoviocytesScandinavian Journal of Rheumatology, 2006
- The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine productionScandinavian Journal of Rheumatology, 2006
- BMP Receptor Signaling Is Required for Postnatal Maintenance of Articular CartilagePLoS Biology, 2004
- Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destructionArthritis & Rheumatism, 2002
- Bone Morphogenetic Protein-2 and Growth and Differentiation Factor-5 Enhance the Healing of Necrotic Bone in a Sheep ModelGrowth Factors, 2001
- Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family.Journal of Clinical Investigation, 1997
- Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.The Journal of Experimental Medicine, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988